In-silico cardiac aging regulatory model including microRNA post-transcriptional regulation by Politano, Gianfranco et al.
In-silico cardiac aging regulatory model including
microRNA post-transcriptional regulation
Gianfranco Politanoa, Federica Lograndb, Mara Brancacciob, Stefano Di
Carloa,∗
aPolitecnico di Torino, Control and Computer Engineering Department, Torino, Italy
bDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino,
Italy
Abstract
In most developed countries, cardiovascular diseases are among the top causes
of death and their development has been shown closely related to aging. In this
context, because of their ability to pervasively influence gene networks, miRs
have been found as possible key players in the development of cardiac patholo-
gies, suggesting their potential role as therapeutic targets or diagnostic markers.
Based on these assumptions, we hereby present a computational study that ap-
plies data fusion techniques coupled with network analysis theory to identify
a regulatory model able to represent the relationship between key genes and
miRs involved in cardiac senescence processes. The proposed model has been
validated through an extensive literature analysis, which confirmed that 94% of
the identified genes and miRs are related with cardiac senescence. Furthermore,
two relevant genes of the model have been also validated by Western blot ex-
periments on heart samples from young and old mice, confirming in vitro their
ectopic expression in aged hearts. The pure computationally inferred model
presented in the paper is therefore a good candidate to represent the relation-
ship between key genes and miRs involved in cardiac senescence processes, and
represents a reliable selection of genes and miRs for further studies, in order to
elucidate and better detail their involvement in cardiac aging.
Keywords: Senescence, heart, omic regulation, pathway, microRNA.
1. Introduction
Physiological aging and senescence progressively impair a large set of phys-
iological functions in living organisms leading to a reduced response to stress
and increasing the risk of occurrence of a wide set of diseases [1, 2].
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At the cardiovascular level, aging often manifests with reduced cardiac func-
tional reserve, left ventricular hypertrophy, mild fibrosis and reduced endoge-
nous cardiac protection [3, 4]. Cardiovascular diseases are one of the leading
causes of death in most developed countries and aging is a dominant risk factor
for their development [5]. Therefore, clearing up the regulatory mechanisms
contributing to cardiac aging may help the identification of early cardiovascular
pathophysiological changes and potentially contributes to the development and
improvement of new therapies [6].
Cardiac aging can be favored by both genetic and environmental factors as
reported in several published studies. Among the others, the most relevant
factors include: decrease in telomerase activity and shortening of the DNA of
the telomeres [7, 8], increased oxidative stress [9], loss of mitochondrial function
[3] and impaired autophagy [10].
Epigenetic regulation from small non-coding RNAs such as micro RNAs
(miRs) also plays a significant role in cell aging processes [11, 12]. miRs are
non-coding RNAs that play a key role in the regulation of gene expression.
They act at the post-transcriptional level suppressing target protein expression
either by promoting messenger RNA (mRNA) degradation or by translational
repression [13, 14, 15, 16, 17, 18, 19]. It has been shown that miRs may fine-
tune the expression of as much as 30% of all mammalian protein-encoding genes
[18], thus influencing a wide spectrum of biological processes such as cell devel-
opment, stem cell proliferation, division and differentiation, regulation of im-
munity, apoptosis, cell signaling and metabolism [15, 17, 18, 20, 21]. Moreover,
aberrant expression of miRs has been associated with the onset and development
of various diseases, such as cancer [18][22] [23], metabolic disorders [24], autoim-
mune diseases [21], acute cellular rejection following transplantation [25, 26] and
cardiac pathologies [27, 28, 29, 30].
In this paper we show the application of a computational workflow that com-
bines data fusion techniques with network analysis theory. Data fusion tech-
niques allow to scrape and integrate a huge amount of information regarding
selected biological processes available in public omic databases, and to combine
them in the form of complex regulatory networks. Network theory is then used
to mine the complexity of the generated networks in order to extract an in-silico
model able to represent the relationship between key genes and miRs involved
in cardiac senescence processes. This model, that extends the preliminary work
presented by the authors in [31], has the potential to support the identification
of molecular mechanisms and pathways involving miRs responsible for cardiac
aging processes. An extensive literature based validation suggests strong con-
nection between genes of the identified model and aging related processes. This
has been further confirmed by Western blot experiments on heart samples from
young (2 month-old) and old (18-month old and 26 month-old) mice on two
relevant genes of the identified model.
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2. Materials and methods
We developed a semi-automated workflow that was able to infer a regulatory
network whose nodes showed a key regulatory role in cardiac aging. Fig. 1 shows
the overall data flow that takes advantage of two Cytoscape plugins: (i) ReNE
[32], and, (ii) NetworkAnalyzer [33]. We started from a list of differentially
expressed genes related to cardiac aging, which allowed us to identify a set
of KEGG’s pathways involving these genes and describing biological processes
related cardiac aging. By integrating these pathways with their transcriptional
and post-transcriptional regulators we were able to compute gene centrality
measures across the networks that eventually allowed us to produce a list of high
centrality nodes. Such nodes resulted well interconnected, resembling a highly
interconnected sub-network able to dispatch key regulatory signals previously
associated with senescence [20].
2.1. Gene selection
A set of genes related to cardiac aging in Rattus norvegicus were identified
from microarray expression data (Affymetrix Rat Genome U34 Array, anno-
tation table with netaffx build 32) available in the Gene Expression Omnibus
(GEO)[34] under accession number GDS399 (http://www.ncbi.nlm.nih.gov/
geoprofiles?term=GDS399[ACCN]). The selected experiment investigates the
effects of reduced adrenergic signaling in the aged heart by comparing young
(3-4 month) and aged (20-22 month) male Fischer-344 heart ventricle [35].
Differentially expressed genes were extracted from the dataset using the GEO
”Up/down filter”. Pseudogenes, expressed sequence tags and duplicates were
removed from the obtained list.
To identify Homo Sapiens homologs the list of genes was loaded in the ReNE
Cytoscape plugins [32] (http://apps.cytoscape.org/apps/rene) and processed us-
ing the ”Genetic information – fast” option of the plugin. This operation looks
for all gene symbols with a valid human unigene id allowing us to remove genes
without human homologs, and to generate a list of differentially expressed genes
named here as Differential Expressed Genes Network (DEGN).
2.2. Pathway selection
Genes contained in DEGN were used to identify a list of pathways from
KEGG [36] involving the identified set of genes and therefore potentially de-
scribing biological processes responsible for the aging process. All pathways in
KEGG were processed using the KEGG mapper API (http://www.genome.jp/
kegg/tool/map_pathway1.html) to count how many genes from DEGN they
contain, identifying a set of 109 Homo sapiens pathways involving genes from
DEGN. The analyzed pathways were ranked according to this gene count. Fig-
ure 2.2 graphically shows the gene count of the top 50 ranked pathways. Looking
at the figure we can see a first area (green section) containing 10 pathways with
high gene count and therefore highly relevant for our analysis. After the first
10 pathways the tendency of the curve is to flatten. We used this distribution
to define a cut-off threshold in this ranked list of pathways. The green area is
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Figure 1: Computational workflow used to infer the cardiac aging model. The workflow starts
from a dataset of microarray expression data and (a) identifies a set of differential expressed
genes in the dataset, (b) uses these genes to identify a set of relevant KEGG networks, (c)
applies data fusion techniques to the selected networks to increase their informative con-
tent, (d) applies network analysis theory on the networks to identify central nodes and (e)
uses the identified central nodes to build the final in-silico model. Cyan elements identify
input/intermediate/output data. Orange blocks are processing tasks resorting to external
services, software or database whereas green block correspond to local tasks.
the area of interest for our analysis. Nevertheless, to avoid loosing important
information we enlarged this area by adding 5 additional pathways from the
rank (orange area) thus selecting a list of 15 top ranked pathways. These top
15 pathways were manually reviewed by a set of experts in order to identify a
list of relevant networks (RN).
2.3. Data fusion
Both the DEGN and the RN were individually processed resorting to the
ReNE Cytoscape plugin [32] to increase their informative content. The following
computational tasks were applied:
1. Naming disambiguation: since different databases use different ways to
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Figure 2: Homo sapiens pathways from KEGG containing genes from DEGN. Pathways are
ranked based on the number of genes they contain. For clarity only the top 50 pathways out
of the 109 identified ones are reported. The full list is available in the supplementary data.
identify omic entities, all symbols contained in the analyzed networks were
converted according to their NCBI [37] and Uniprot [38] unique identifiers,
thus allowing to navigate across public omic repositories without ambigu-
ities. This operation was performed resorting to the ”Genetic information
– fast” functionality offered by ReNE.
2. Transcriptional information integration: it is well known that miR medi-
ated post-transcriptional regulation of selected genes is not always a direct
interaction but is often indirectly mediated by translational repression or
mRNA degradation of their transcription factors (TFs) [20, 39, 40, 32].
Considering these indirect interactions is therefore very important. How-
ever, pathway stored in KEGG lack systematic information regarding TFs.
The TFs of each gene of the analyzed networks were systematically re-
trieved from TargetMine [41] and integrated in the analyzed networks
creating new TF nodes with outgoing edges directed to their target genes.
This operation was performed using the ReNE ”Transcription Factors –
Add TF” functionality.
3. Post-transcriptional information integration: information regarding miRs
hosted by the network genes, not available in KEGG, was retrieved from
the miRIAD database [42] using the ReNE ”Intronic miRNA” functional-
ity and added to the analyzed networks. It is well-known that these miRs
are co-expressed with their host genes [43] and often act as regulatory
hubs that lead to complex post-transcriptional regulatory motifs acting
as fine tuning genetic regulatory signaling cascades. For each identified
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miR the list of its targets was computed by ReNE using the ”Intronic
miRNA targets” functionality that resorts to information available in the
TargetHUB online database [44], thus connecting miRs with their targets
in the pathways.
2.4. Network analysis
Network topology parameters were computed for each processed network us-
ing the Cytoscape NetworkAnalyzer plugin [33]. In detail, centrality measures
were computed for each node of the analyzed networks, since they have been
demonstrated particularly useful to identify key players in biological processes
[45][46]. NetworkAnalyzer provides two centrality measures: (i) closeness cen-
trality, and (ii) betweenness centrality. The closeness centrality uses information
about the length of the shortest paths within a network. However, since this
distance is only defined for pairwise strongly connected nodes, it cannot be used
in our experimental setup. On the other hand, the betweenness centrality quan-
tifies the ability of a node to monitor the communication between other nodes.
Every node that is part of a shortest path between two nodes can monitor
the communication on the path. Counting how many communications a node
can monitor provides an intuitive definition of centrality [45]. Shortest-path
betweenness centrality was applied to mammalian transcriptional regulatory
networks and it was noted that betweenness appears to be an interesting topo-
logical characteristic in regard to the biological significance of distinct elements
[47].
Betweenness centrality was therefore exploited to identify nodes whose role is
central enough to possibly induce misbehavior when ectopically expressed under
aging conditions according to the algorithm reported in Figure 3. The algorithm
first analyzes each network filtering the nodes according to their betweenness
centrality and retaining only the top T1 nodes (lines 1 – 4). It then analyzes all
possible pairs of networks searching for common nodes in each pair (lines 5 – 9).
This information is used to construct a histogram able to sort nodes according to
the number of times they concurrently appear in a couple of networks, i.e., those
nodes that have the potential to jointly influence more than one network (lines
10 – 18). The top T2 nodes of the histogram are selected as list of high centrality
nodes. Such nodes are promising regulators with a key role in signaling cascades
related to aging.
Selecting the two thresholds T1 and T2 is not an easy task and basically
depends on the target size for the final model. However, some basic considera-
tions can be taken into account when selecting these two thresholds. Threshold
T1 performs a filtering working locally on each single network. Among the two
thresholds, T1 is the most selective one. Setting a low level for T1 means that
each network retains only very few nodes with high betweenness. This means
that in the second part of the selection algorithm only those nodes that are
high in rank in several networks will have a chance to enter the construction
of the histogram and will therefore have a role in the construction of the final
model. This in turns focuses the model toward the most informative genes,
discarding the less connected genes. Threshold T2 instead simply acts on the
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final histogram enabling to have a fine control on the size of the model. This
is particularly important whenever time consuming validation activities must
be performed on the identified genes. In this paper we selected both T1 and
T2 equal to 40 genes. Considering that in this paper we worked with networks
whose average size is 600 nodes, the selected T1 threshold allowed us to have
a very strong filtering working on average with only the top 7% of the genes of
each network and therefore focusing on the most informative genes. Threshold
T2 was instead selected in order to keep the complexity of the validation analy-
sis under control. It is worth to remark, that the two thresholds affect the size
of the model incrementally. Relaxing the constraint would only have the effect
of increasing the size of the model adding additional information.
Require: Cut-off thresholds T1,T2
Output: List of central nodes
1: for i = 1 to count(nets) do
2: sort desc nodes of nets[i] by betweenness
3: nets[i] = top T1 nodes of nets[i]
4: end for
5: for i = 1 to count(nets) do
6: for j = 1 to count(nets) do
7: cg[i,j] = nets[i] ∩ nets[j]
8: end for
9: end for
10: for each distinct node n in cg do
11: for i = 1 to count(nets) do
12: for j = 1 to count(nets) do
13: if g ∈ cg[i,j] then
14: histogram[n]++
15: end if
16: end for
17: end for
18: end for
19: sort desc histogram;
20: return (top T2 nodes of histogram[)
Figure 3: Selection of central nodes of a network.
2.5. Model generation
High centrality nodes identified in the previous step were finally mapped to
a global network. The ”Merge multiple pathways” functionality of the ReNE
Cytoscape plugin was used to merge all the analyzed networks (DEGN plus
RN) into a single global model. The merging process produced a large network
that was finally filtered in order to retain only relations involving the identified
central nodes thus reducing its complexity. This filtered subnetwork is a good
candidate to highlight the most important inter-pathways regulatory entities,
defined accordingly to their high centrality.
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3. Results
A set of 191 differentially expressed genes out of 8,799 available microarray
data were identified using the GEO ”Up/down filter” on the GSE421 Dataset.
The list was preprocessed removing non-genes references and duplicates (see
Section 2.1) obtaining a list 166 candidate differentially expressed genes (DEGN)
in heart aging. By looking for human homologs of the identified genes the
following entities have been discarded: Gstm7, LOC687048, LOC100365443,
LOC100363469, LOC688869, Reg3b, LOC100364956, LOC100360403, Ly6al,
LOC290595, Olr1642, RT1-M4, LOC100362894, Kng1l1, thus obtaining a list
of 152 human homologs with a valid NCBI ID.
KEGG pathways were ranked according to these 152 genes (see Section 2.2)
and the 15 top ranked pathways were manually analyzed selecting the following
7 relevant networks (RN):
• MAPK (hsa04010): MAP kinases are involved in many different cellular
functions like apoptosis, proliferation, survival, growth arrest, differenti-
ation, motility, metabolism and senescence. Alterations in the MAPK
signaling pathway have been reported in several tissues during aging [48].
• Rap1 (hsa04015): promotes integrin and cadherin signaling and is acti-
vated by shear stress to regulate NO production in endothelial cells. Rap1
deficiency in murine endothelium leads to endothelial dysfunction and hy-
pertension, common diseases in the elderly [49].
• Neuroactive ligand-receptor interaction (hsa04080): cardiovascular dis-
eases and aging are both associated with changes in the neurohumoral
system, mainly adrenergic and renin-angiotensin systems. In particular,
it has been reported a decrease in catecholamine-responsiveness in the el-
derly [50] and its regulatory effect in pathways disturbed in heart failure
[51].
• cAMP (hsa04024): is a secondary messenger generated by adenylate cy-
clase, downstream to β-adrenergic signaling. Genetic inhibition of cAMP
signaling in the mouse myocardium protects against heart failure, attenu-
ates heart aging and prolongs lifespan (interestingly, in the heart of these
mice, the Raf1 /MEK /ERK and the AKT pathways are activated) [52].
• PI3K-Akt (hsa04151): controls a multitude of biological processes in my-
ocardial cells, e.g., cardiomyocyte hypertrophy, survival, energy produc-
tion, contractility, and response to stress. Some evidences indicate that
attenuation of the PI3K /AKT pathway contributes to age related changes
in myocardium [53].
• Alzheimer’s disease and Huntington’s disease (hsa05010, hsa05016): pro-
tein misfolding plays a crucial role in neurodegenerative diseases. In-
creasing evidences indicate that, in the myocardium, mechanical and ox-
idative stress together with other pathological conditions lead to protein
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misfolding and that misfolded proteins play a relevant role in the onset
and progression of cardiomyopathies [54]. Recently, extensive links have
been identified between Alzheimer’s disease and cardiovascular diseases in
large-scale genome-wide association studies [55].
Interestingly after this manual review all selected pathways are from the
green area of Figure 2.2.
As a result of the transcriptional and post-transcriptional information inte-
gration described in Section 2.3, three new TF nodes and seven miR nodes were
globally inserted in the processed networks. Moreover, as a result of this pro-
cess, the list of genes in the DEGN was connected and transformed into a new
network thus obtaining a list of eight processed networks qualitatively depicted
in Fig. 3-A. These networks were processed as described in Section 2.4, thus
identifying the list of 35 central nodes reported in Table 1.
Table 1: List of 35 identified central nodes.
NAME TYPE NAME TYPE
ADCY1 Gene PTOV1 Gene
BRAF Gene RAF1 Gene
C00575 Gene RAP1A Gene
CHUK Gene RAPGEF3 Gene
CREB3 Gene RRAS2 Gene
CSF1R Gene ST8SIA4 Gene
EIF4A2 Gene TECR Gene
ENO1 Gene hsa-miR-1248 miR
FAS Gene hsa-miR-208A miR
GNAQ Gene hsa-miR-4691 miR
MYH6 Gene hsa-miR-639 miR
NDUFS8 Gene hsa-miR-661 miR
MAP2K1 Gene hsa-miR-6728 miR
MAP2K3 Gene hsa-miR-7113 miR
MAPK1 Gene MYC TF
PIK3R5 Gene NFKB1 TF
PLCB1 Gene TP53 TF
PLEC Gene
Finally, the 8 networks were merged obtaining a very large network qualita-
tively reported in Fig. 3-B. The network complexity was reduced by collapsing
protein nodes into their related coding genes (protein information are only re-
quired for intermediate processing) obtaining a network composed of 914 nodes
(i.e., genes, TFs, and, miRs) and 6,527 edges. By filtering this complex network
with the set of identified central nodes we were able to extract a sub-network
containing 35 interconnected nodes qualitatively depicted in Fig. 3-C. A detailed
view of the network depicting the 35 identified regulators and their interactions
is reported in Fig. 5. This network represents the proposed in-silico regulatory
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model of cardiac aging.
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Figure 4: Conceptual processing steps. A – Seven KEGG networks (hsa0401, hsa04015,
hsa04024, hsa04080, hsa04151, hsa05010 and hsa05016), and a list of 152 differentially ex-
pressed genes (extracted from GEO) were processed using ReNE to add transcriptional and
post-transcriptional regulators (green nodes: miRs, dark blue nodes: TFs, red nodes: pro-
teins). B – the processed networks were merged resulting in a large merged network. C –
after centrality analysis nodes with highest betweenness centrality were extracted along with
their regulatory links, resulting in a small filtered network.
All input data, intermediate and final results, procedures and source code
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of the scripts used to process the data are reported in the supp-data.zip file
available as supporting file for this paper.
4. Discussion
The proposed model was validated by both a very extensive literature review
and by Western blot experiments on heart samples from young (2 month-old)
and old (18-month old and 26 month-old) mice on two relevant genes of the
model.
4.1. Literature validation
Literature validation confirmed that the nodes of the filtered subnetwork
have been reported in different studies on heart aging response.
For the sake of clarity, the role of the identified genes, miRs and TFs was
mapped to six main functional classes:
1. inflammatory responses,
2. senescence regulation,
3. beta-adrenergic signaling,
4. MAP2K and ERK1/2 signaling pathways,
5. miRs,
6. Transcription factors.
Five out of the seven identified miRs and all three identified TFs were re-
ported as involved in senescence or inflammatory processes. Their role is of
particular interest because they can finely tune the network behavior shad-
ing new light into the complex regulatory mechanisms underlying senescence.
Overall, 32 out of the 35 network nodes (94%) have been previously reported in
studies on aging related processes. The two missing nodes, i.e., miR-4691and
miR-7113, represent two interesting candidates for future investigations. In par-
ticular, miR-4691 with his role of regulatory hub with 9 regulated nodes is a
particularly interesting node to be investigated in laboratory.
4.1.1. Inflammatory Response related genes
NDUFS8. mitochondria are necessary for the pro-inflammatory and pro-oxidant
features of senescent phenotype. Their biogenesis stabilizes senescence via a
crosstalk with the ATM, Akt, and mTOR signaling pathways. Since the in-
creased mitochondrial mass is invariably reduced by rapamycin the mTOR path-
way has a central role in mitochondrial regulation. mTOR inhibition results in
a down expression of mTOR complex 1 (mTORC1 ), which integrates stress
signals into the regulation of protein and lipid synthesis and autophagy, all of
which are involved in the complex pathways mediating mitochondrial homeosta-
sis. In this context, NDUFS8 is a mTORC1 downstream regulated gene and
its presence may be an hallmark of mitochondrial regulation [56].
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EIF4A2. is a member of the helicase family. Helicases are known as guardians
of the genome given their role in various DNA metabolic pathways that in-
clude DNA recombination, replication, repair, transcription and telomere main-
tenance. EIF4A2 seems related to aging by influencing protein translation and
mitochondrial translocation efficiency [57].
ENO1. studies reported that ENO1 is an auto-antigen that has been recog-
nized as a common marker of systemic autoimmune diseases and inflammatory,
degenerative and other pathological disorders. It is induced by cellular stress
and promote cell growth, glycolysis, migration, and invasion [58].
CSF1R. the colony-stimulating-factor receptor-1 (CSF1R) is a type III receptor
tyrosine kinase primarily reported as responsible for the proliferation, differen-
tiation and survival of the monocyte–macrophage cell lineage, as well as their
recruitment. Two ligands (CSF1 and IL34 ) function through non-competitive
binding to CSF1R by activating both phosphatidylinositol 3-kinase PI3K -dependent
and RAS -activated protein kinase-dependent pathways. Senescent cells also re-
vealed that AKT inhibition in CSFR-expressing cells is accompanied by the
ectopic regulation of CDKN1A, SOX2, OCT4 and c-MYC proteins. This es-
tablishes an interesting link between the expression of CSF1R, AKT activation
and physical crosstalk between the PI3K, AKT, STAT3, and NFKB pathways
[59].
PLCB1. acts as catalyst for the formation of inositol 1,4,5-trisphosphate and
diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction plays
an important role in the intracellular transduction of many extracellular sig-
nals. PLCB1 has been identified as a pro-inflammatory regulator involved in
several cardiovascular diseases as acute, inflammatory, and self-limited vasculi-
tis, Kawasaki Syndrome, endothelial cell inflammation with varying degrees of
pro-inflammatory cytokine expression, and coronary artery aneurysm. [60]
4.1.2. Senescence Regulation
PLEC. laminar shear stress (LSS) caused by blood flow is known to regulate en-
dothelial function and to contribute to vascular health. However endothelial cell
senescence seems to increase the incidence of cardio vascular disorders. PLEC1
is an actin binding protein induced in endothelial cells exposed to LSS. Studies
demonstrated that several actin binding proteins including PLEC1 may play a
critical regulatory role in the endothelial wound healing under LSS conditions
[61].
BRAF. constitutive activation of BRAF may drive the proliferation and matu-
ration/senescence of melanoblasts. In mature human skin, descendant melanoblasts
reside in the epidermis but they colonize all the tissues of the body, such as the
valves of the heart and the meninges [62].
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GNAQ. its mutations have been associated with defects in platelet activation
and aggregation, and port-wine stains. It is involved in estradiol-responsive
pathway and produces age-related differences in functional pathways related to
oxidative phosphorylation, synaptic plasticity, and estrogen responsive signaling
cascades. GNAQ has also been recently reported as possibly responsible (with
NRAS/BRAF -mutations) for transcriptional modifications in uveal melanoma
and blue nevi that lead to melanoblast proliferation and melanocyte differenti-
ation [62].
CREB3. is a regulator known to physically associate with the endomembrane
system. It has been found ectopically expressed in abnormal lysosomes with
impaired function. Abnormalities of lysosomal functions are characteristic of
cellular senescence, organismal ageing, atherosclerosis, Alzheimer’s and other
diseases. Ectopic secretion of lysosomal proteases can, in fact, degradate extra-
cellular matrix, contributing to atherosclerosis, arthritis, aneurysms formation,
and other diseases [63].
MYH6
myosin-6 has been demonstrated ectopically regulated in senescent rats against
young rats [64].
FAS. is a TNF receptor, shown to activate NFKB, MAPK3/ERK1, and MAPK8/JNK
pathways. It is involved in transducing the proliferating signals in normal diploid
fibroblast and T-cells. FAS appears impaired in senescence-associated secretory
phenotype (SASP) proteases, i.e., cleave FAS ligand and other cell surface pro-
teins required for effective immune function. The macrophage responses result
declining with aging, potentially contributing to senescent cell accumulation in
old age, which eventually results in a reduced immune function [65].
ADCY1. encodes a member of the of adenylate cyclase gene family. ADCY1
has been identified as functionally responsible for enhanced forskolin-stimulated
association with ERK that eventually contributes to cAMP elevation in vascular
smooth muscle cells. cAMP over expression in the plasma membrane intensely
strengthen the endothelial barrier function, resulting in cardiac rejuvenation,
and suggests possibly regenerative potential in aged tissues. ADCY1 ectopic
activity is also proven sufficient to overwhelm the barrier protective effects of
plasma membrane activity to promote endothelial gap formation [66].
CHUK. encodes a member of the serine/threonine protein kinase family. The
encoded protein is an inhibitor of the transcription factor NFKB complex. In
aging, reduced inhibition of NFKB is associated with the pro-inflammatory
phenotype in vascular endothelium [67].
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4.2. Beta-Adrenergic signaling
Chronic activation of beta-adrenergic signaling is deleterious to cardiac func-
tion resulting in increased heart rate, contractility, peripheral vasoconstric-
tion and wall stress. Stimulation of beta-adrenergic receptors decreases anti-
apoptotic and anti-oxidative stress signaling contributing to senescence and
functional deterioration in a cascading effect with downstream induction of
cAMP and PKA that act as inhibitors of the cardioprotective Raf/MEK/Erk
pathways. In aging human heart, the functional responsiveness of the human
cardiac beta-adrenoceptor system decreases along with all the effects mediated
by cAMP.
PTOV1. androgens have been considered to reduce the incidence of ischemic
myocardial disease in men, but they have also been reported to exert athero-
genic effects on the human cardiovascular system through promoting plaque
formation and enhancing monocyte adhesion to endothelial cells. In this con-
text, PTOV1 is considered to be one of the testosterone-induced genes involved
in androgen-mediated stimulation of VSMC proliferation. PTOV1 may thus
play an important role in androgen-related atherogenesis in the male human
aorta [68].
TECR. is a poorly characterized testosterone reduction enzyme member of
steroid 5-alpha reductase family, which also contains SRD5A2L2, SRD5A1,
SRD5A2, SRD5A3. SRD5A1 and SRD5A2 have been already identified as
encoders for proteins targeted in treatments against prostate cancer and male
pattern hair loss (male aging related diseases). However the role of TECR is
still not clear. It has been shown to be involved in the elongation of very long
chain fatty acids and reduction of a non-steroid lipid. NbECR, a TECR homolog
in Nicotiana Benthamiana, has been identified as responsible for disorganized
membrane structures and epidermal cell ablation. Those assumptions make
TECR a candidate as processor for adrenergic and hormonal signals, capable to
possibly lead to vascular membranes impairment [69, 70].
C00575 (cAMP). cAMP is a second messenger used for intracellular signal
transduction such as transferring into cells the effects of hormones like glucagon
and adrenaline, which cannot pass through the plasma membrane. cAMP
also regulates the function of ion channels and a few other cyclic nucleotide-
binding proteins such as RAPGEF3. Exchange proteins activated by cAMP
(RAPGEFx ), when cAMP binds, expose the activated GEF domain, allowing
them to activate small Ras-like GTPase, such as RAP1 [71].
RAP1. a GTPase superfamily member highly involved in cell motility and junc-
tion formation. It acts as a substrate for protein kinase A and interacts with
NADPH oxidase (a group of multimeric enzymes whose activity results in the
production of O2). In non-phagocytic cells, homologues of the NADPH oxi-
dase were found in vascular endothelial cells and smooth muscle cells or trans-
formed cells such as melanoma. Activation of RAP1 strengthens cell junction
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integrity and reduces cell migration by affecting actin cytoskeleton remodeling
[72]. RAP1 also acts as a protective protein for telomeres by relocalizing to
the upstream promoter regions of hundreds of new target genes when critical
telomere shortening happens. RAP1 role in delaying senescence and concurring
in DNA damage responses makes it (and its surrounding regulators) a good
candidate for actively managing senescence [73].
4.3. MAP2K and ERK1/2 signaling pathways
Activation of β-adrenergic receptors results in the production of cyclic AMP
which in turn phosphorylates many transcriptional factors via the MAPK path-
way and thus, stimulates protein synthesis and cell growth. In the filtered
network, we identified a central cluster of genes that recurs in several high rel-
evance pathways: Ras, Raf, MAP2K, and, ERK1/2 signaling pathways. Such
pathways are also highly interconnected to each other showing a concurrent role
in crucial cell-survival regulations. At the cellular level, the ERK1/2 pathway
regulates cell cycle progression, proliferation, cytokinesis, transcription, differ-
entiation, senescence, cell death, migration, GAP junctions formation, actin and
microtubule networks, and cell adhesion. MAPK pathway plays a role in many
biological functions like cell cycle regulation, apoptosis, cell survival, senescence,
differentiation, and cell growth and migration.
RRAS2. encodes a small GTPase involved in diverse processes including an-
giogenesis, vascular homeostasis and regeneration, and cell adhesion. RAS pro-
teins interact with multiple effectors, including RAF kinases, PI-3 kinases, and
activate multiple downstream signaling cascades. Of particular interest the
RAS/mitogen-activated protein kinase RAS/MAPK signaling pathway, which
plays a central role in cellular proliferation and differentiation. RRAS2 also
plays a key role in Noonan syndrome, an autosomal-dominant disorder charac-
terized by congenital heart defects. [74]
ST8SIA4. is predominantly expressed in immune cells. It plays an important
role in substrate recognition that modulates cell adhesion and signaling. Fur-
thermore, ST8SIA4 mediates the activity of PI3K/Akt signal pathway in a
competitive way. Inhibition of PI3K/Akt pathway is also able to attenuate the
effects caused by the overexpression of ST8SIA4 on MDR [75].
RAPGEF3. is necessary for antioxidant and antiapoptotic effects of exendin,
which has an essential role in cardiomyocytes and is involved in the develop-
ment of heart failure. RAPGEF3 also drives the inhibitions of oxidative stress
and apoptosis in cardiomyocytes thanks to GLP-1R which helps in cardiopro-
tection, and also inactivates myosin light chain kinase [76]. Elevated levels
of cAMP activate RAPGEF3 which, in turn, leads to GTP binding to Rap1.
This causes changes to the cortical cytoskeleton and organization of vascular
endothelial cadherin in the endothelial junctions, leading to reduced endothelial
permeability. Ectopic expression of RAPGEF3 may thus result in cell aging
effect [77].
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RAF1. its activation engages the phosphorylation cascade starting from RAF1
(MKKK ) to MAP2K, and then to the MAPK family. RAF1 was found to
be an activator of MAP2K in mammalian cells and to form a stable complex
with MAP2K. Prototypically, growth factors activate RAS which recruits and
activates RAF at the plasma membrane. Once activated, RAF phosphorylates
and activates MAP2K, which in turn activates ERK1/2. Eventually activated
ERK1/2 can phosphorylate downstream proteins in the cytoplasm or nucleus,
including many transcription factors. Cardiac specific deletion of RAF1 leads
to heart failure without hypertrophy in the absence of external stress, and also
increases apoptosis [78].
PIK3R5. activates the Ras-Raf-MAP2K-ERK signalling cascade. PI3K also
represents a downstream target of active RAS. Suppression of PI3K prevents
lipofuscin accumulation in aged heart tissue. Lipofuscin is thought to be gener-
ated from damaged proteins and post mitotic cells (such as cardiac myocytes)
accumulate a large amount of lipofuscin in old age. Inhibition of PI3K, in fact,
prevents the expression of cellular senescence markers (by decreasing the accu-
mulation of lipofuscin in heart tissue) and most of the age-related changes of
gene expression [79, 80].
MAPK1/MAP2K3/MAP2K1. the MAPK cascade is composed of RAS, RAF1,
MAP2K, MAPK1 and RSK. It spans from the plasma membrane to the nu-
cleus and trasduces the mitogenic signals downstream from the tyrosine kinase
membrane receptor. The first subgroup of MAPK (ERK1/2 ) plays an im-
portant role in the signaling pathway responsible for the G0 to G1 transition
in the cell cycle. The MAPK1 pathway is coupled by a GTP-binding protein
(Gαq-protein isoform in the heart) that activates the ERK1/2 pathway. The
activation of the ERK1/2 pathway in heart is lead by a GTP-binding protein
(Gαq-protein isoform) that produces diacylglycerol (DAG) and inositol-3,4,5-
triphosphate (InsP3 ). DAG then activates the MAPK1 signaling cascade,
while InsP3 activates the MAPK1 pathway via both RAS -dependent and -
independent mechanisms. The activity of MAPK1 is stimulated by multiple
extracellular stimuli and oncogenes. Its activation regulates several cellular pro-
tein kinases, and catalyzes the phosphorylation of some nuclear transcription
factors [80]. Finally, mutations in HRAS, KRAS, BRAF, and MAP2K have also
been discovered to be involved in other genetic disorders with cardiac develop-
mental defects, such as LEOPARD syndrome, cardio-facio-cutaneous syndrome,
and Costello syndrome [78].
4.3.1. miRs
MiRs are key regulators of gene expression. By binding to multiple genes at
once, they create a complex network of post-transcriptional fine co-regulations.
miR-6728. has been demonstrated to be able to regulate several genes associ-
ated with cardiometabolic phenotypes [81].
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miR-639. recently emerged as potential novel biomarker of Human bone mar-
row mesenchymal stem cells aging [82].
miR-661. has been demonstrated to have a regulatory role in small GTPase
signalling. It also has an active role in phosphorylation of myosin II and up
regulates the cell invasion, indicating a possible oncogenic miR [83]. miR-661
is also highly associated with nano-sized vesicles released by activated CD4+ T
lymphocytes release [84] showing a correlation with inflammatory response, and
with the modulation of the endogenous levels of iNOS and nitrite production
via MTA1 mediated control. [85]
miR-1248. studies investigating the relationships between miR profiles and ag-
ing reported that serum expression levels of miR-1248 were significantly lower
in old participants (mean age, 64 years) than in young participants (mean age,
30 years). miR-1248 was found to regulate the expression of mRNAs related
to several cytokines (age-associated cytokines IL6 and IL8 ) and inflammatory-
associated pathways (including NF-kB), thus suggesting a relevant role in the
aging process. miR-1248 also influences the impaired DNA repair capacity, then
decreased levels of miR-1248 due to aging directly affect DNA repair pathways
[86].
miR-208a. targets thyroid hormone receptor associated protein 1 (THRAP1 )
and myostatin, which are negative regulators of muscle growth and hypertrophy.
It is particularly relevant in cardiac myocytes, since its transgenic overexpression
in the heart is sufficient to induce hypertrophic growth and arrhythmias in
mice. miR-208a also has a key role in the expression of cardiac transcription
factors, like homeodomain-only protein (HOP) and GATA4, and for the gap
junction protein connexin. Upregulation of miR-208a was observed in samples
of infarcted heart tissue from patients with myocardial infarction compared
to healthy adult hearts. Given its high sensitivity in early setting of acute
myocardial infarction (AMI), miR-208a seems a reliable biomarker for early
AMI diagnosis in humans [29]
4.3.2. Transcription factors
TP53. TP53 encodes a tumor suppressor protein, whose expression is stabilized
by DNA damage. In order to suppress tumor development, TP53 has a key role
in leading to senescence as mechanism to prevent tumor formation and to have
a trade-off relation with cancer. Overexpression of TP53, in fact, induces cell
cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism [58].
NFKB1. is a binding subunit of the NFKB protein complex, a transcription
regulator that acts as hub by aggregating multiple intra- and extra-cellular
stimuli (i.e., cytokines, oxidant-free radicals, ultraviolet irradiation, pathogens).
Ectopic activation of NFKB has been associated with inflammatory diseases and
inappropriate immune cell development or delayed cell growth. In particular,
the NFKB1 subunit is known to be responsible for proinflammatory arterial
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phenotype developed with aging, and is associated to vascular dysfunctions due
to impaired nitric oxide processing [87].
MYC. is a multi-functional, nuclear phosphoprotein that plays a role in cell
cycle progression, apoptosis and cellular transformation. MYC is necessary and
sufficient for the regulation of Nucleostemin (NS ) (a nucleolar protein regulating
stem cell proliferation and pluripotency). NS regulation is essential to preserve
the regenerative potential of aging stem cells by antagonizing senescence and
by enhancing myocardial regeneration. Levels of MYC, positive transcriptional
regulators of the cell cycle, are decreased in myocardial senescence along with
elevated levels of TP53, which eventually result in enlarged myocytes, reduced
number of cardiomyocytes, disfigured mitochondrial morphology, telomere at-
trition, up-regulation of molecular markers of senescence, and decline in cardiac
function resembling a heart failure phenotype [88].
4.4. Wet Lab assessment
The expression levels of two proteins belonging to the MAPK cascade (RAF1
– coded by RAF1 gene and MEK1 – coded by the MAP2K1 gene) and identified
in the in-silico analysis were tested by Western blot on heart samples from young
(2 month-old) and old (18-month old and 26 month-old) mice.
Western blot was performed as described in [89]. Briefly: hearts were lysed
in RIPA buffer (25 mM Tris–HCl pH 7.6, 150 mM NaCl,1% NP-40, 1% sodium
deoxycholate, 0.1% SDS) containing Roche complete protease inhibitor cocktail,
10 mM NaF, 1 mM PMSF and 1 mM Na3VO4. Protein extracts were clarified
with three sequential centrifugations for 20 minutes at 20,000 g, at 4°C. The
following antibodies were used: MEK1/2 (Cell Signaling), RAF1 (Santa Cruz)
and Vinculin (Sigma).
Both proteins showed a decreased expression in old mice (see Fig. 6), sup-
porting in-silico data. This is particularly relevant since the MAPK pathway
plays a crucial role in adaptation to stress conditions and it has been involved in
both adaptive or maladaptive cardiac remodeling [90]. Activation of the MAPK
cascade has been described as a protective signal in a number of stressful condi-
tions as myocardial infarction [91, 92, 93] and pressure overload [94, 95]. In this
view, underexpression of components of the pathway may cause insensitivity to
external stimuli and an impairment in heart adaptation.
5. Conclusions
This paper presented a pure computationally inferred model that is able
to represent the relationship between key genes and miRs involved in cardiac
senescence processes. Interestingly, all the newly introduced regulators, except
for two miRs (i.e., miR-4691 and miR-7133), appear strongly related to previ-
ous studies on aging related mechanisms. Giving the results obtained on the
other regulators, these two miRs represent good candidate for further studies
to elucidate their possible involvement in cardiac aging.
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Figure 5: The resulting cardiac aging model. Nodes are colored to highlight their differ-
ent roles: in purple Beta-Adrenergic signaling related nodes, inflammatory response in red,
MAPK-Erk1/2 in yellow, senescence regulation in pale violet, microRNAs in green, and, tran-
scription factors in blue. Edges are colored according to the following criteria: red for miR
post-transcriptional repression, green for miR co-transcription with their host gene, and black
for regulations inherited from KEGG’s pathways.
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Figure 6: Western blot analysis of heart protein extracts from young (2 month-old) and old (18-
month old and 26 month-old) mice for MEK1/2 and RAF1 expression. Vinculin was used as loading
control.
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